Melissa Gelormini - FIXX Old Senior Resources
Executive
Melissa Gelormini is Senior Resources of FIXX Old
| Phone | 781 301 7277 |
| Web | https://www.homologymedicines.com |
FIXX Old Management Efficiency
The company has return on total asset (ROA) of (0.364) % which means that it has lost $0.364 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9002) %, meaning that it created substantial loss on money invested by shareholders. FIXX Old's management efficiency ratios could be used to measure how well FIXX Old manages its routine affairs as well as how well it operates its assets and liabilities.FIXX Old currently holds 1.32 M in liabilities with Debt to Equity (D/E) ratio of 0.14, which may suggest the company is not taking enough advantage from borrowing. FIXX Old has a current ratio of 8.27, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about FIXX Old's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Dr JD | 4D Molecular Therapeutics | 53 | |
| John Lunger | Adaptimmune Therapeutics Plc | 55 | |
| Dana Lynch | Adaptimmune Therapeutics Plc | N/A | |
| Kerry Sharp | Adaptimmune Therapeutics Plc | N/A | |
| Karen Carothers | 4D Molecular Therapeutics | 74 | |
| Shamim MS | Stoke Therapeutics | 65 | |
| Erika Jones | Black Diamond Therapeutics | 40 | |
| Thomas Leggett | Stoke Therapeutics | 47 | |
| Sue Browne | Passage Bio | N/A | |
| FAAAAI FAAP | 4D Molecular Therapeutics | 63 | |
| Uneek Mehra | 4D Molecular Therapeutics | 52 | |
| MD BA | Adaptimmune Therapeutics Plc | 61 | |
| Dennis Williams | Adaptimmune Therapeutics Plc | N/A | |
| JD Esq | Passage Bio | 61 | |
| Stuart Henderson | Passage Bio | N/A | |
| Jonathan JD | Stoke Therapeutics | 34 | |
| Gregory Fuest | Passage Bio | N/A | |
| Jason Hoitt | Stoke Therapeutics | 47 | |
| Noriyuki MD | 4D Molecular Therapeutics | 62 | |
| Karl Whitney | Passage Bio | N/A | |
| Christopher Simms | 4D Molecular Therapeutics | 50 | |
Management Performance
| Return On Equity | -0.9 | |||
| Return On Asset | -0.36 |
FIXX Old Leadership Team
Elected by the shareholders, the FIXX Old's board of directors comprises two types of representatives: FIXX Old inside directors who are chosen from within the company, and outside directors, selected externally and held independent of FIXX. The board's role is to monitor FIXX Old's management team and ensure that shareholders' interests are well served. FIXX Old's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, FIXX Old's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael MBA, Chief Officer | ||
| Melissa Gelormini, Senior Resources | ||
| Saswati Chatterjee, CoFounder Board | ||
| CPA Michaud, Corporate Finance | ||
| Paul JD, President COO | ||
| Deborah Kinch, Chief Officer | ||
| Julie MD, Sr Operations | ||
| Theresa McNeely, Chief Advocate | ||
| Cara Mayfield, Director Communications | ||
| Albert Seymour, Chief Scientific Officer |
FIXX Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is FIXX Old a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.9 | |||
| Return On Asset | -0.36 | |||
| Operating Margin | (78.85) % | |||
| Current Valuation | (27 M) | |||
| Shares Outstanding | 3.23 M | |||
| Shares Owned By Insiders | 9.20 % | |||
| Shares Owned By Institutions | 46.75 % | |||
| Number Of Shares Shorted | 338.72 K | |||
| Price To Earning | (10.00) X | |||
| Price To Book | 0.04 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in FIXX Stock
If you are still planning to invest in FIXX Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the FIXX Old's history and understand the potential risks before investing.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |